These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37421996)

  • 21. Noninferiority Margins in Trials of Thrombectomy Devices for Acute Ischemic Stroke: Is the Bar Being Set Too Low?
    Lin CJ; Saver JL
    Stroke; 2019 Dec; 50(12):3519-3526. PubMed ID: 31619155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reporting of noninferiority trials was incomplete in trial registries.
    Dekkers OM; Soonawala D; Vandenbroucke JP; Egger M
    J Clin Epidemiol; 2011 Sep; 64(9):1034-8. PubMed ID: 21444195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noninferiority Margin Size and Acceptance of Trial Results: Contingent Valuation Survey of Clinician Preferences for Noninferior Mortality.
    Pong S; Fowler RA; Mitsakakis N; Murthy S; Pernica JM; Gilfoyle E; Bowen A; Fontela P; Seto W; Science M; Hutchison JS; Jouvet P; Rishu A; Daneman N
    Med Decis Making; 2022 Aug; 42(6):832-836. PubMed ID: 35583116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of Multiplicity and Appropriate Adjustments Among Cardiovascular Randomized Clinical Trials Published in Major Medical Journals.
    Khan MS; Khan MS; Ansari ZN; Siddiqi TJ; Khan SU; Riaz IB; Asad ZUA; Mandrola J; Wason J; Warraich HJ; Stone GW; Bhatt DL; Kapadia SR; Kalra A
    JAMA Netw Open; 2020 Apr; 3(4):e203082. PubMed ID: 32301992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using a single noninferiority margin or preserved fraction for an entire pharmacological class was found to be inappropriate.
    Althunian TA; de Boer A; Groenwold RHH; Klungel OH
    J Clin Epidemiol; 2018 Dec; 104():15-23. PubMed ID: 30009941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statistical issues and recommendations for noninferiority trials in oncology: a systematic review.
    Tanaka S; Kinjo Y; Kataoka Y; Yoshimura K; Teramukai S
    Clin Cancer Res; 2012 Apr; 18(7):1837-47. PubMed ID: 22317762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel approach to noninferiority testing: documented proof rather than arbitrary margins.
    Cleophas TJ; Zwinderman AH
    Am J Ther; 2012 Mar; 19(2):101-7. PubMed ID: 20975529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inadequate Reporting of Cointerventions, Other Methodological Factors, and Treatment Estimates in Cardiovascular Trials: A Meta-Epidemiological Study.
    Bührer J; Del Giovane C; Gencer B; Adam L; Lyko C; Feller M; Da Costa BR; Aujesky D; Bauer DC; Rodondi N; Moutzouri E
    Mayo Clin Proc Innov Qual Outcomes; 2023 Aug; 7(4):231-240. PubMed ID: 37304064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis.
    Catalá-López F; Aleixandre-Benavent R; Caulley L; Hutton B; Tabarés-Seisdedos R; Moher D; Alonso-Arroyo A
    Trials; 2020 Jan; 21(1):34. PubMed ID: 31910857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reporting of noninferiority and equivalence randomized trials for major prostaglandins: a systematic survey of the ophthalmology literature.
    Eyawo O; Lee CW; Rachlis B; Mills EJ
    Trials; 2008 Dec; 9():69. PubMed ID: 19055743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Superiority Claims for Spinal Devices: A Systematic Review of Randomized Controlled Trials.
    Golish SR; Groff MW; Araghi A; Inzana JA
    Global Spine J; 2020 May; 10(3):332-345. PubMed ID: 32313799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized trials published in higher vs. lower impact journals differ in design, conduct, and analysis.
    Bala MM; Akl EA; Sun X; Bassler D; Mertz D; Mejza F; Vandvik PO; Malaga G; Johnston BC; Dahm P; Alonso-Coello P; Diaz-Granados N; Srinathan SK; Hassouneh B; Briel M; Busse JW; You JJ; Walter SD; Altman DG; Guyatt GH
    J Clin Epidemiol; 2013 Mar; 66(3):286-95. PubMed ID: 23347852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unresolved issues with noninferiority pragmatic trials: Results of a literature survey.
    Ciarleglio MM; Li J; Peduzzi P
    Clin Trials; 2024 Apr; 21(2):242-256. PubMed ID: 37927102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the Justification, Funding, Success, and Survival Outcomes of Randomized Noninferiority Trials of Cancer Drugs: A Systematic Review and Pooled Analysis.
    Gyawali B; Tessema FA; Jung EH; Kesselheim AS
    JAMA Netw Open; 2019 Aug; 2(8):e199570. PubMed ID: 31469391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of Mortality as an Endpoint in Noninferiority Trials May Lead to Ethically Problematic Conclusions.
    Hersh AM; Walter RJ; Abberegg SK
    J Gen Intern Med; 2019 Apr; 34(4):618-623. PubMed ID: 30756306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mixed noninferiority margin and statistical tests in active controlled trials.
    Tsou HH; Hsiao CF; Chow SC; Yue L; Xu Y; Lee S
    J Biopharm Stat; 2007; 17(2):339-57. PubMed ID: 17365228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inconsistencies in the Methodological Framework Throughout Published Studies in High-Impact Orthopaedic Journals: A Systematic Review.
    Docter S; Lukacs MJ; Fathalla Z; Khan MCM; Jennings M; Liu SH; Dong S; Getgood A; Bryant DM
    J Bone Joint Surg Am; 2022 Jan; 104(2):181-188. PubMed ID: 34648473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the Quality of Abstracts in Randomized Controlled Trials Published in High Impact Cardiovascular Journals.
    Khan MS; Shaikh A; Ochani RK; Akhtar T; Fatima K; Khan SU; Mookadam F; Murad MH; Figueredo VM; Doukky R; Krasuski RA
    Circ Cardiovasc Qual Outcomes; 2019 May; 12(5):e005260. PubMed ID: 31030545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative effectiveness clinical trials in psychiatry: superiority, noninferiority, and the role of active comparators.
    Leon AC
    J Clin Psychiatry; 2011 Oct; 72(10):1344-9. PubMed ID: 21367350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revisiting Intermittent Therapy in Metastatic Prostate Cancer: Can Less Be More in the "New World Order"?
    Shevach J; Sydes MR; Hussain M
    Eur Urol Focus; 2019 Mar; 5(2):125-133. PubMed ID: 30803926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.